Koers Alexion Pharmaceuticals, Inc.
Aandelen
ALXN
US0153511094
Farmaceutische producten
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Marc Dunoyer
CEO | Chief Executive Officer | 71 | - |
Sean Christie
DFI | Director of Finance/CFO | - | 01-08-21 |
Chief Tech/Sci/R&D Officer | - | 01-12-20 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+33,46% | 701 mld. | |
+26,24% | 570 mld. | |
+0,93% | 381 mld. | |
+21,03% | 334 mld. | |
+17,51% | 322 mld. | |
+0,74% | 209 mld. | |
+2,95% | 212 mld. | |
-6,05% | 205 mld. | |
-3,61% | 157 mld. |